Michael V. Mazya

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 629 citations · Full text

Medicine, Neurology, Pharmacology +10

Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase

Michael V. Mazya, J. Egido, Gary A. Ford et al. · Stroke · 2012 · 381 citations · Full text

Medicine, Internal Medicine, Risk Analysis +16

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke

George Ntaios, Patrik Michel, Georgios Georgiopoulos et al. · Stroke · 2020 · 284 citations · Full text

Medicine, Infectious Diseases, Cerebrovascular Neurosurgery +15

Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11–13 November 2018

Niaz Ahmed, Heinrich J. Audebert, Guillaume Turc et al. · European Stroke Journal · 2019 · 173 citations · Full text

Medicine, Neurology, Clinical Medicine +11

Minor stroke due to large artery occlusion. When is intravenous thrombolysis not enough? Results from the SITS International Stroke Thrombolysis Register

Michael V. Mazya, Charith Cooray, Kennedy R. Lees et al. · European Stroke Journal · 2017 · 100 citations · Full text

Medicine, Neurology, Neurosurgery +17